RecruitingNot ApplicableNCT07509177

An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy

Photobiomodulation Radiant Intervention for Stress in Epilepsy


Sponsor

Cynthia Kerson

Enrollment

80 participants

Start Date

Aug 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Do you have Epilepsy? Would you like to participate in a study using PhotoBioModulation (PBM)? PBM is being researched for potential benefits in resolving many stress-related brain disorders. It is a non-invasive technique that delivers light energy to cells and tissues that can promote brain stabilization and self-regulation, cell repair, reduce oxidative stress, and enhance cellular function. We ask you to participate for about 3-4 months and come to our facility for 30 minute sessions 3x a week for 15 weeks. You will receive extensive metabolic testing and an Õura ring for your participation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Photobiomodulation for people with epilepsy. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPhotobiomodulation

Transcranial photobiomodulation emits low light (infrared) through the scalp and energizes mitochondria, which in turn produce more energy. It is assumed that many brain-related disorders are afflicted with this phenomenon.


Locations(4)

Brain Health Center Miami

North Miami, Florida, United States

Right Mind Wellness Center

Cincinnati, Ohio, United States

Holly Maggiano, MD

Warren, Ohio, United States

Houston Neuroscience Brain Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07509177


Related Trials